Projects per year
We demonstrated that a whole-blood androgen receptor-based multigene signature was an important prognostic tool in a cohort of metastatic castration-resistant prostate cancer (mCRPC)patients receiving contemporaneous systemic treatment. This signature may have a valuable role in upfront risk stratification and prognostication of mCRPC patients.
- Androgen receptor
- Androgen receptor splice variant
- Castration-resistant prostate cancer
- 1 Finished